Based in Boston and listed on the London Stock Exchange (LSE: ALM), Allied Minds plc is an IP commercialisation company focused on technology and life sciences. With extensive access to U.S. federal government laboratories and universities, as well as partnerships with leading U.S. corporations, Allied Minds forms, funds, and operates a portfolio of companies with the objective of delivering successful liquidity events that will generate attractive long-term returns for its investors and stakeholders. Allied Minds supports its businesses with capital, resources, and expertise. Company Snapshot Investment philosophy We invest in innovative technologies that have the potential to disrupt large and growing markets. Typically we will option a license over a target technology, performing diligence on the science, IP situation, and commercialisation potential, before deciding whether to exercise the option and release seed investment funds. We tend to finance the seed round 100% in-house. And then to look for opportunities to syndicate our investment from Series A and beyond, with a particular focus on strategic investors who can provide validation and offer the potential to accelerate or de-risk the path to commercialisation. We are owner-operators, aiming in general to retain majority ownership until at least Series B, and providing management and capital resource, expertise and share service support.

Stock ExchangeLSE
IndustryFinancial Services
CountryUnited Kingdom
World RegionEurope
CEO"Ms. Jill Deborah Smith "
Registered Year

  2017 2016 2015
  € m € m € m
Total interest income
Total Interest Expenses
Net Interest income
Total Net Revenue
Earnings per share      
Basic 0.32 0.44 0.36
Diluted 0.32 0.44 0.36
Total current assets 1,84,792 2,32,007 1,58,427
Other assets 668 990 1,518
Total assets 2,13,161 2,70,239 2,51,211
Total current liabilities 2,00,202 1,55,402 1,08,974
Total liabilities 2,01,069 1,56,122 1,09,837
Total Equity 71,333 1,34,914 1,52,005
Net income      
Net cash provided by operating activities 91 95 82
Net cash used for investment activities 4 71 75
Net cash provided by financing activities 35 128 38
Currency in EUR, All numbers in million.      

United States